The Xpert® Xpress SARS-CoV-2 is a rapid, near-patient test for the detection of the 2019 novel coronavirus that causes COVID-19 that leverages the design principles of Cepheid’s current Xpert® Xpress Flu/RSV cartridge technology, in which multiple regions of the viral genome are targeted. The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in as soon as 30 minutes for positive results with less than a minute of hands on time to prepare the sample.
The Xpert® Xpress SARS-CoV-2/Flu/RSV four-in-one test is expected to deliver qualitative detection of SARS-CoV-2, Flu A, Flu B and RSV from a single patient sample. The test is designed for use on any of Cepheid's more than 25,000 GeneXpert® Systems placed worldwide, with results expected in as little as 35 minutes.
The Xpert MRSA/SA BC can carry out accurate molecular detection of MRSA or SA from a gram-positive blood culture sample in about an hour. Its simple test protocol can be run on all shifts to provide results around-the-clock and provides clinicians actionable information when it is most needed.